Pierre Gravier

Pierre Gravier

DirectoratPTC Therapeutics· In proxies 2023–2025

Pay in FY2024-19% from the year before · PTC Therapeutics stock +63.8% the same year

Pierre Gravier was paid $2.2M in FY2024 (Dec), down 19%. PTC Therapeutics stock rose 63.8% that year.

Pay$100 in the stock at the end of FY22 → $118
Pay is from the Summary Compensation Table of each PTC Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Filana TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. PTC TherapeuticsPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +79%

Roles come from the proxy statements of each company.

Boards1

  • Filana TherapeuticsDirector · 2 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

Two people shown as one, or a wrong number?